15 years. That’s how long it can take to develop a new drug. While AI can in fact transform clinical trials, the real opportunity lies in bringing it into the process much earlier. That’s where AI co-scientists come in. x.com/NatureBiotech/…

AGI doesn’t have to be something we fear. In fact, it should be the opposite. That’s why SingularityNET is focused on beneficial AGI (BGI) and why Ben Goertzel highlights the importance of decentralization of AI. Open, AI-powered science is just one example.

The team at SingularityNET did a fantastic job of inviting world-class researchers to the AGI-25 Conference. Wondering what our CEO has to say about one of the talks? See below:

Our CEO, Kennedy Matsagas Schaal, will take the stage at ARDD Meeting, the world’s biggest conference on aging research. We will share how AI biomedical research tools, going far beyond GenAI and ChatGPT, shape discovery, validation, and development in aging-related science.

Come see me at the ARDD Meeting on FriYAY afternoon, 29 August

With the ARDD Meeting conference right around the corner, we’re looking back at last year’s interview where Kennedy Matsagas Schaal talked about the journey of building our platform. youtu.be/yKrRHthlVbk?si…

The ARDD Meeting kicks off today! Bags unpacked, badges picked up and coffee secured. We’re set for a full week of thought-provoking discussions. Catch Kennedy Matsagas Schaal at our booth!

The energy at ARDD Meeting is incredible and biotech innovations gather huge interest. Even better: reconnecting with experts (and old friends) like Alex Zhavoronkov, PhD (aka Aleksandrs Zavoronkovs)! Truly a golden time for longevity AI research.

Another day at ARDD Meeting, another round of inspiring conversations! Honored to connect with brilliant minds like Phil Newman (Longevity Technology) and Dylan Livingston (The Alliance for Longevity Initiatives (A4LI)), both pushing the impact of the longevity industry.

We couldn't miss a chance to show the demo of our AI Co-Scientist platform during ARDD Meeting! A perfect way to finish a full week at the "Longevity Davos".

Rejuve Biotech's Co-Scientist platform leverages OpenCog Hyperon to streamline and optimize research in life sciences, accelerating drug discovery and addressing the most pressing global health challenges.

Academic research is slow, gatekept, and hidden behind paywalls. DeSci says it can fix that! But can we actually decentralize science? Is it real progress, or just a buzzword for investors? This week on The BOOM ROOM, we dig into what's broken, what DeSci promises, and

Listen in as our CEO, Kennedy Matsagas Schaal, shares the story of AI and DeSci and their impact on the longevity field. youtu.be/s2Knv2jIpQ0?si…

Open science with open source AI is the way.

Our CEO, Kennedy Matsagas Schaal, joined Max More, Jose Cordeiro and Chris Kudla for a panel at #BGI25 to discuss the future of biology.